DK0406216T3 - Protein-S-holdigt farmaceutisk præparat - Google Patents

Protein-S-holdigt farmaceutisk præparat

Info

Publication number
DK0406216T3
DK0406216T3 DK90890184.6T DK90890184T DK0406216T3 DK 0406216 T3 DK0406216 T3 DK 0406216T3 DK 90890184 T DK90890184 T DK 90890184T DK 0406216 T3 DK0406216 T3 DK 0406216T3
Authority
DK
Denmark
Prior art keywords
protein
pharmaceutical composition
containing pharmaceutical
preparation
content
Prior art date
Application number
DK90890184.6T
Other languages
English (en)
Inventor
Yendra Dr Linnau
Hans Peter Dr Schwarz
Ewald Dr Molinari
Susanne Dipl-Ing Pfeiler
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0406216T3 publication Critical patent/DK0406216T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4866—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK90890184.6T 1989-06-26 1990-06-18 Protein-S-holdigt farmaceutisk præparat DK0406216T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0155189A AT402153B (de) 1989-06-26 1989-06-26 Protein-s-hältige pharmazeutische präparation

Publications (1)

Publication Number Publication Date
DK0406216T3 true DK0406216T3 (da) 1994-01-17

Family

ID=3515833

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90890184.6T DK0406216T3 (da) 1989-06-26 1990-06-18 Protein-S-holdigt farmaceutisk præparat

Country Status (10)

Country Link
US (1) US5143901A (da)
EP (1) EP0406216B1 (da)
JP (1) JPH0338528A (da)
AT (2) AT402153B (da)
CA (1) CA2019745C (da)
DE (1) DE59003060D1 (da)
DK (1) DK0406216T3 (da)
ES (1) ES2061007T3 (da)
FI (1) FI94927C (da)
NO (1) NO902823L (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256642A (en) * 1988-04-01 1993-10-26 The Johns Hopkins University Compositions of soluble complement receptor 1 (CR1) and a thrombolytic agent, and the methods of use thereof
US6458360B1 (en) 1990-04-25 2002-10-01 The Johns Hopkins University Soluble complement regulatory molecules
WO1993009807A1 (en) * 1991-11-18 1993-05-27 The Scripps Research Institute Methods of inhibiting thrombosis via elevation of circulating endogenous activated protein c levels
DK0658168T3 (da) * 1992-08-27 2001-01-22 Sanquin Bloedvoorziening Antistoffer, som er specifikke for et hæmostatisk protein, anvendelse heraf til isolering af intakt protein, hæmostatiske p
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
AU2001238034A1 (en) * 2000-02-04 2001-08-14 The Scripps Research Institute Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
CN115884986A (zh) * 2020-06-29 2023-03-31 Inserm(法国国家健康医学研究院) 抗蛋白s单域抗体和包含其的多肽

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258288A (en) * 1986-07-25 1993-11-02 Genzyme Corporation Vector containing DNA encoding mature human protein S
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
WO1989002747A1 (en) * 1987-10-05 1989-04-06 The American National Red Cross Therapeutic thrombolytic composition

Also Published As

Publication number Publication date
EP0406216A3 (en) 1991-02-06
JPH0338528A (ja) 1991-02-19
ATE95818T1 (de) 1993-10-15
FI94927C (fi) 1995-11-27
AT402153B (de) 1997-02-25
US5143901A (en) 1992-09-01
CA2019745A1 (en) 1990-12-26
ATA155189A (de) 1996-07-15
FI903197A0 (fi) 1990-06-26
NO902823D0 (no) 1990-06-25
EP0406216A2 (de) 1991-01-02
NO902823L (no) 1990-12-27
ES2061007T3 (es) 1994-12-01
EP0406216B1 (de) 1993-10-13
DE59003060D1 (de) 1993-11-18
FI94927B (fi) 1995-08-15
CA2019745C (en) 1996-12-31

Similar Documents

Publication Publication Date Title
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
NZ210275A (en) Modified hirudin and its antithrombin properties
DE69006628D1 (de) Pharmazeutische Zusammensetzung, enthaltend Loratadin, Ibuprofen und Pseudoephedrin.
ID29393A (id) Komposisi pengobatan kanker dan metoda penggunaan minyak-minyak esensil tanaman alamiah
NZ228130A (en) Therapeutic composition comprising fenofibrate and a solid surfactant which has been co-micronised; preparatory process
FI901949A7 (fi) Happoa kestävä FGF-koostumus ja menetelmä ruuansulatuskanavassa esiint yvien, haavaumia aiheuttavien sairauksien hoitamiseksi
ATE95818T1 (de) Protein-s-haeltige pharmazeutische praeparation.
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
DE68921908D1 (de) Zell-assoziierte Glucosyltransferase, Antikörper dagegen und eine diese enthaltende Zusammensetzung zur Prophylaxe von Karies.
IL101675A (en) Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
ZA894945B (en) Strontium salt,process for the preparation thereof and pharmaceutical compositions containing it
AU1086888A (en) Primary biliary cirrhosis autoantigen
NO894008D0 (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
KR920017668A (ko) 암 전이 억제 또는 예방 방법 및 이를 위한 제제
MX9201825A (es) Composicion farmaceutica que contiene calcitonina.
DE69331008D1 (de) Verwendung von cotinin zur linderung des tabakentzugssyndrom
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
IE900460L (en) Pharmaceutical composition
KR910000165A (ko) 비경구 투여용 fr 115224 물질의 제제
EP0351790A3 (de) Verfahren zur Bestimmung von Fructosamin
SE8802323D0 (sv) 8alfa-acylaminoergoline, its preparation and pharmaceutical compositions containing it
DE3782661D1 (de) Pharmazeutische zusammensetzungen zur behandlung von krebs.
IT1248867B (it) Composizione farmaceutica per il trattamento della ascite aviaria
WO1994015962A3 (en) Derivatized calcitonins

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment